{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T01:48:29Z","timestamp":1791856109303,"version":"4.3.4"},"reference-count":55,"publisher":"Oxford University Press (OUP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,2]]},"DOI":"10.1093\/humrep\/del407","type":"journal-article","created":{"date-parts":[[2006,11,13]],"date-time":"2006-11-13T21:04:09Z","timestamp":1163451849000},"page":"317-322","source":"Crossref","is-referenced-by-count":83,"title":["Polycystic ovary syndrome, oral contraceptives and metabolic issues: new perspectives and a unifying hypothesis"],"prefix":"10.1093","volume":"22","author":[{"given":"S.","family":"Nader","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Diamanti-Kandarakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2006,11,10]]},"reference":[{"key":"key\n\t\t\t\t20171012102318_b1","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1093\/qjmed\/94.1.31","article-title":"Insulin action and insulin secretion in polycystic ovary syndrome treated with ethinyl\/estradiol\/cyproterone acetate","volume":"94","author":"Armstrong","year":"2001","journal-title":"Q J Med"},{"key":"key\n\t\t\t\t20171012102318_b2","first-page":"995","article-title":"The evaluation and management of hirsutism","volume":"101","author":"Azziz","year":"2003","journal-title":"Obstet Gynecol"},{"key":"key\n\t\t\t\t20171012102318_b3","doi-asserted-by":"crossref","first-page":"3863","DOI":"10.1210\/jc.2004-1958","article-title":"Association between the current use of low-dose oral contraceptives and cardiovascular arterial disease: a metaanalysis","volume":"90","author":"Baillargeon","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t20171012102318_b4","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1093\/humupd\/7.6.522","article-title":"Polycystic ovary syndrome cancer","volume":"7","author":"Balen","year":"2001","journal-title":"Hum Reprod Update"},{"key":"key\n\t\t\t\t20171012102318_b5","doi-asserted-by":"crossref","first-page":"3621","DOI":"10.1210\/jc.2003-030328","article-title":"Glucose metabolism and insulin resistance in women with polycystic ovary syndrome during therapy with oral contraceptives containing cyproterone acetate or desogestrel","volume":"88","author":"Cagnacci","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t20171012102318_b6","doi-asserted-by":"crossref","first-page":"23S","DOI":"10.1016\/S0010-7824(98)00079-1","article-title":"Uniqueness of oral contraceptive progestins","volume":"58","author":"Carr","year":"1998","journal-title":"Contraception"},{"key":"key\n\t\t\t\t20171012102318_b7","doi-asserted-by":"crossref","first-page":"330","DOI":"10.2337\/diacare.20.3.330","article-title":"A prospective study of oral contraceptives and NIDDM among U.S. women","volume":"20","author":"Chasen-Taber","year":"1997","journal-title":"Diabetes Care"},{"key":"key\n\t\t\t\t20171012102318_b8","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1093\/humrep\/16.5.940","article-title":"Does obesity diminish the positive effect of oral contraceptive treatment on hyperandrogenism in women with polycystic ovarian syndrome?","volume":"16","author":"Cibula","year":"2001","journal-title":"Hum Reprod"},{"key":"key\n\t\t\t\t20171012102318_b9","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1093\/humrep\/17.1.76","article-title":"Insulin sensitivity in non-obese women with polycystic ovary syndrome during treatment with oral contraceptives containing low androgenic progestin","volume":"17","author":"Cibula","year":"2002","journal-title":"Hum Reprod"},{"key":"key\n\t\t\t\t20171012102318_b10","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1093\/humrep\/deh588","article-title":"The effect of combination therapy with metformin and combined oral contraceptives (COC) versus COC alone on insulin sensitivity, hyperandrogenemia, SHBG and lipids in PCOS patients","volume":"20","author":"Cibula","year":"2005","journal-title":"Hum Reprod"},{"key":"key\n\t\t\t\t20171012102318_b11","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1210\/jc.2005-1666","article-title":"Adolescent girls with polycystic vary syndrome have an increased risk of the metabolic syndrome associated with increasing androgen levels independent of obesity and insulin resistance","volume":"91","author":"Coviello","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t20171012102318_b12","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.1093\/humrep\/13.10.2706","article-title":"Effects of two antiandrogen treatments on hirsutism and insulin sensitivity in women with polycystic ovary syndrome","volume":"13","author":"Dahlgren","year":"1998","journal-title":"Hum Reprod"},{"key":"key\n\t\t\t\t20171012102318_b13","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1016\/j.fertnstert.2004.11.070","article-title":"Prevalence of insulin resistance in the polycystic ovary syndrome using the homeostatic model assessment","volume":"83","author":"De Ugarte","year":"2005","journal-title":"Fertil Steril"},{"key":"key\n\t\t\t\t20171012102318_b14","doi-asserted-by":"crossref","first-page":"4006","DOI":"10.1210\/jcem.84.11.6148","article-title":"A survey of polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile","volume":"84","author":"Diamanti-Kandarakis","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t20171012102318_b15","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1210\/jc.2002-021528","article-title":"A modern medical quandary: polycystic ovary syndrome, insulin resistance and oral contraceptive pills","volume":"88","author":"Diamanti-Kandarakis","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"689","key":"key\n\t\t\t\t20171012102318_b16","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1136\/bmj.1.5689.149","article-title":"Effects of obesity, glucocorticoid, and oral contraceptive therapy on plasma glucose and blood pyrvate levels","volume":"1","author":"Doar","year":"1970","journal-title":"Br Med J"},{"key":"key\n\t\t\t\t20171012102318_b17","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1056\/NEJMra041536","article-title":"Polycystic ovary syndrome","volume":"352","author":"Ehrmann","year":"2005","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20171012102318_b18","first-page":"2044","article-title":"Long term testosterone administration increases visceral fat in female to male transsexuals","volume":"82","author":"Elbers","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t20171012102318_b19","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1093\/humrep\/17.7.1729","article-title":"Clinical, endocrine and metabolic effects of metformin added to ethinyl\/estradiol-cyproterone acetate in non-obese women with polycystic ovary syndrome: a randomized control study","volume":"17","author":"Elter","year":"2002","journal-title":"Hum Reprod"},{"key":"key\n\t\t\t\t20171012102318_b20","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S0015-0282(00)00718-4","article-title":"Treatment of hirsutism with ethinyl\/estradiol \u2013 desogestal contraceptive pills has beneficial effects on the lipid profile and improves insulin sensitivity","volume":"74","author":"Escobar-Morreale","year":"2000","journal-title":"Fertil Steril"},{"key":"key\n\t\t\t\t20171012102318_b21","doi-asserted-by":"crossref","first-page":"56","DOI":"10.3109\/00016349509009945","article-title":"Effects of long-term administration of an oral contraceptive containing ethinylestradiol and cyproterone acetate on lipid metabolism in women with polycystic ovary syndrome","volume":"74","author":"Falsetti","year":"1995","journal-title":"Acta Obstet Gynecol Scand"},{"key":"key\n\t\t\t\t20171012102318_b22","first-page":"1","article-title":"The influence of female sex steroids on glucose metabolism and insulin action","volume":"738","author":"Godsland","year":"1996","journal-title":"J Intern Med Suppl"},{"key":"key\n\t\t\t\t20171012102318_b23","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1210\/jc.2003-031158","article-title":"Drospirenone for the treatment of hirsute women with polycystic ovary syndrome: a clinical, endocrinological, metabolic pilot study","volume":"89","author":"Guido","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t20171012102318_b24","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1067\/mob.2001.117415","article-title":"Preclinical profiles of progestins used in formulations of oral contraceptives and hormone replacement therapy","volume":"185","author":"Hammond","year":"2001","journal-title":"Am J Obstet Gynecol"},{"key":"key\n\t\t\t\t20171012102318_b25","first-page":"252","article-title":"Oral contraceptives, tubal sterilization and functional ovarian cyst risk","volume":"102","author":"Holt","year":"2003","journal-title":"Obstet Gynecol"},{"key":"key\n\t\t\t\t20171012102318_b26","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1093\/humrep\/deh329","article-title":"Flutamide-metformin plus an oral contraceptive (OC) for young women with polycystic ovary syndrome: switch from third- to fourth-generation OC reduces body adiposity","volume":"19","author":"Ibanez","year":"2004","journal-title":"Hum Reprod"},{"key":"key\n\t\t\t\t20171012102318_b27","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1210\/jc.2003-031281","article-title":"Ethinylestradiol-drospirenone, flutamide-metformin, or both for adolescents and women with hyperinsulinemic hyperandrogenism: opposite effects on adipocytokines and body adiposity","volume":"89","author":"Ibanez","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t20171012102318_b28","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1210\/jc.2004-1405","article-title":"Flutamide-metformin plus ethinylestradiol-drospirenone for lipolysis and antiatherogenesis in young women with ovarian hyperandrogenism: the key role of metformin at the start and after more than one year of therapy","volume":"90","author":"Ibanez","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t20171012102318_b29","doi-asserted-by":"crossref","first-page":"4716","DOI":"10.1210\/jc.2004-0047","article-title":"Flutamide-metformin plus ethinylestradiol-drospirenone for lipolysis and antiatherogenesis in young women with ovarian hyperandrogenism: the key role of early, low-dose flutamide","volume":"89","author":"Ibanez","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t20171012102318_b30","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1056\/NEJMcp033487","article-title":"Acne","volume":"352","author":"James","year":"2005","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20171012102318_b31","first-page":"3327","article-title":"Metabolic effects of oral contraceptives in women with polycystic ovary syndrome","volume":"80","author":"Korytkowski","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t20171012102318_b32","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S0015-0282(02)02993-X","article-title":"Androgen and lipid profiles in adolescents with polycystic ovary syndrome who were treated with two forms of combined oral contraceptives","volume":"77","author":"Mastorakos","year":"2002","journal-title":"Fertil Steril"},{"key":"key\n\t\t\t\t20171012102318_b33","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.2337\/diabetes.48.10.2039","article-title":"Insulin resistance during puberty: results from clamp studies in 357 children","volume":"48","author":"Moran","year":"1999","journal-title":"Diabetes"},{"key":"key\n\t\t\t\t20171012102318_b34","first-page":"3161","article-title":"Endocrine and metabolic effects of metformin versus ethinyl\/estradiol cyproterone acetate in obese women with polycystic ovary syndrome: a randomized study","volume":"85","author":"Morin-Papunen","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t20171012102318_b35","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1210\/jc.2002-020997","article-title":"Metformin versus ethinyl\/estradiol-cyproterone acetate in the treatment of non-obese women with polycystic ovary syndrome","volume":"88","author":"Morin-Papunen","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t20171012102318_b36","first-page":"3074","article-title":"The effect of desogestrel-containing oral contraceptives on glucose tolerance and leptin concentrations in hyperandrogenic women","volume":"82","author":"Nader","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t20171012102318_b37","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1783\/1471189041261636","article-title":"An observational study of Yasmin in the management of polycystic ovary syndrome","volume":"30","author":"Palep-Singh","year":"2004","journal-title":"J Fam Plann Reprod Health Care"},{"key":"key\n\t\t\t\t20171012102318_b38","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1046\/j.1365-2265.1999.00701.x","article-title":"The natural history of the metabolic syndrome in young women with polycystic ovary syndrome and the effect of long-term oestrogen-progestogen treatment","volume":"50","author":"Pasquali","year":"1999","journal-title":"Clin Endocrinol"},{"key":"key\n\t\t\t\t20171012102318_b39","first-page":"3188","article-title":"Gender factors affecting fatty acids-induced insulin resistance in non-obese humans: effects of oral steroidal contraception","volume":"86","author":"Perseghin","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t20171012102318_b40","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0010-7824(99)00107-9","article-title":"Metabolic and fibrinolytic response to changed insulin sensitivity in users of oral contraceptives","volume":"60","author":"Petersen","year":"1999","journal-title":"Contraception"},{"key":"key\n\t\t\t\t20171012102318_b41","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/0010-7824(90)90039-X","article-title":"Progestational and androgenic receptor binding affinities and in vivo activities of norgestimate and other progestins","volume":"41","author":"Phillips","year":"1990","journal-title":"Contraception"},{"key":"key\n\t\t\t\t20171012102318_b42","first-page":"265","article-title":"Induction of insulin resistance by androgens and estrogens","volume":"79","author":"Polderman","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t20171012102318_b43","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome","volume":"81","author":"Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group","year":"2004","journal-title":"Fertil Steril"},{"key":"key\n\t\t\t\t20171012102318_b44","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1007\/BF00401427","article-title":"Oral contraception use and the risk of type 2 diabetes in a large prospective study of women","volume":"35","author":"Rimm","year":"1992","journal-title":"Diabetologia"},{"key":"key\n\t\t\t\t20171012102318_b45","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/S0015-0282(03)02162-9","article-title":"Sibutramine has a positive effect on clinical and metabolic parameters in obese patients with polycystic ovary syndrome","volume":"80","author":"Sabuncu","year":"2003","journal-title":"Fertil Steril"},{"key":"key\n\t\t\t\t20171012102318_b46","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S0015-0282(16)55862-2","article-title":"Effects of a 1 year treatment with a low-dose combined oral contraceptive containing ethinyl estradiol and cyproterone acetate on glucose and insulin metabolism","volume":"59","author":"Scheen","year":"1993","journal-title":"Fertil Steril"},{"key":"key\n\t\t\t\t20171012102318_b47","first-page":"S7","article-title":"Classification and pharmacology of progestins. Maturitas 46S","volume":"1","author":"Schindler","year":"2003"},{"key":"key\n\t\t\t\t20171012102318_b48","first-page":"861","volume-title":"Clinical Gynecologic Endocrinology and Infertility","author":"Speroff","year":"2005","edition":"7th"},{"key":"key\n\t\t\t\t20171012102318_b49","first-page":"389","article-title":"Oral contraceptive use and glucose metabolism in a national sample of women in the United States","volume-title":"Am J Obstet Gynecol","author":"Troisi","year":"2000"},{"key":"key\n\t\t\t\t20171012102318_b50","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/0010-7824(90)90034-S","article-title":"Effects of seven low-dose combined oral contraceptives on sex hormone binding globulin, corticosteroid binding globulin, total and free testosterone","volume":"41","author":"Van der Vange","year":"1990","journal-title":"Contraception"},{"key":"key\n\t\t\t\t20171012102318_b51","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1067\/mob.2002.119179","article-title":"Different effects of oral contraceptives containing levonorgestrel or desogestrel on plasma lipoproteins and coagulation factor VII","volume":"186","author":"Van Rooijen","year":"2002","journal-title":"Am J Obstet Gynecol"},{"key":"key\n\t\t\t\t20171012102318_b52","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1046\/j.1365-2133.2002.04798.x","article-title":"Effects of minoxidil 2% vs. cyproterone acetate treatment on female androgenic alopecia: a controlled, 12 month randomized trial","volume":"146","author":"Vexiau","year":"2002","journal-title":"Br J Dermatol"},{"key":"key\n\t\t\t\t20171012102318_b53","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1093\/humupd\/dmi005","article-title":"Combined oral contraceptives in the treatment of polycystic ovary syndrome","volume":"11","author":"Vrbikova","year":"2005","journal-title":"Hum Reprod Update"},{"key":"key\n\t\t\t\t20171012102318_b54","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1530\/eje.0.1500215","article-title":"Metabolic and endocrine effects of treatment with peroral or transdermal oestrogen in conjunction with peroral cyproterone acetate in women with polycystic ovary syndrome","volume":"150","author":"Vrbikova","year":"2004","journal-title":"Eur J Endocrinol"},{"issue":"7624","key":"key\n\t\t\t\t20171012102318_b55","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S0140-6736(69)90477-2","article-title":"Some effects of oral contraceptives on carbohydrate metabolism","volume":"2","author":"Wynn","year":"1969","journal-title":"Lancet"}],"container-title":["Human Reproduction"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/humrep\/article-pdf\/22\/2\/317\/9683761\/del407.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,10,12]],"date-time":"2017-10-12T10:29:49Z","timestamp":1507804189000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/humrep\/article\/22\/2\/317\/2939482\/Polycystic-ovary-syndrome-oral-contraceptives-and"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,11,10]]},"references-count":55,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2006,11,10]]},"published-print":{"date-parts":[[2007,2]]}},"URL":"https:\/\/doi.org\/10.1093\/humrep\/del407","relation":{},"ISSN":["1460-2350","0268-1161"],"issn-type":[{"value":"1460-2350","type":"electronic"},{"value":"0268-1161","type":"print"}],"subject":[],"published-other":{"date-parts":[[2007,2]]},"published":{"date-parts":[[2006,11,10]]}}}